Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|February 24, 2005
The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT)Mohan Suntharalingam, Jerry Jaboin, Rodney Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|March 20, 2019
Downstream Effect of a Proton Treatment Center on an Academic Medical CenterJill S Remick, Søren M Bentzen, Charles B Simone, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2013
Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographicsHao Zhang, Shan Tan, Wengen Chen, et al.
The Journal of Biological Chemistry|September 24, 2002
Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2Jae J Song, Juong G Rhee, Mohan Suntharalingam, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 4, 2011
Prevalence and correlates of symptoms and uncertainty in illness among head and neck cancer patients receiving definitive radiation with or without chemotherapyMary Ellen Haisfield-Wolfe, Deborah B McGuire, Karen Soeken, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapyAnna Strongin, Susannah Yovino, Rodney Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lungMohan Suntharalingam, Rebecca Paulus, Martin J Edelman, et al.
American Journal of Clinical Oncology|August 6, 2010
Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patternsMatthew Koshy, Bruce D Greenwald, Petr Hausner, et al.
The Annals of Thoracic Surgery|October 7, 2004
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancerJoshua R Sonett, Mohan Suntharalingam, Martin J Edelman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 11, 2012
Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapyShan Tan, Seth Kligerman, Wengen Chen, et al.
Pageof 9